ACM
GMAB icon

Ativo Capital Management’s Genmab GMAB Stock Holding History

Ativo Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,442
Closed -$1M – 55
2023
Q3 		$1M Sell
28,442
-299
-1% -$11.4K 1.13% 35
2023
Q2 		$1.09M Buy
+28,741
New +$1.15M 1.15% 34
2021
Q3 		– Sell
-34,096
Closed -$1.39M – 130
2021
Q2 		$1.39M Sell
34,096
-2,396
-7% -$92.5K 0.59% 76
2021
Q1 		$1.2M Buy
36,492
+11
+0% +$414 0.51% 84
2020
Q4 		$1.48M Buy
36,481
+29
+0.1% +$1.08K 0.64% 48
2020
Q3 		$1.33M Buy
+36,452
New +$1.32M 0.64% 51

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ativo Capital Management's GMAB Position: Q4 2023 in Review

Ativo Capital Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 28,442 shares — an estimated $1M sold.

Ativo Capital Management first reported a position in GMAB in Q3 2020 and held it in 6 quarters. The position peaked at $1.48M in Q4 2020. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Ativo Capital Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Ativo Capital Management sold 28,442 Genmab shares in Q4 2023, an estimated $1M.
  • Ativo Capital Management first reported a position in Genmab in Q3 2020 and held it in 6 quarters.
  • Ativo Capital Management's Genmab position peaked at $1.48M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Ativo Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.